General Information of This Drug (ID: DM4I6XK)

Drug Name
TB-402   DM4I6XK
Synonyms Anti-FVIII MAb 2E9; MAb-LE2E9; TGX-LE2E9
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Atrial fibrillation DIS15W6U BC81.3 Phase 2 [1]
Venous thromboembolism DISUR7CR BD72 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT00793234) Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT00793234) Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery. U.S. National Institutes of Health.